Enhancing activity of artesunate against breast cancer cells via induced-apoptosis pathway by loading into lipid carriers

References

• Chadha R, Gupta S, Pathak N. 2012. Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies. Drug Dev Ind Pharm. 38:1538–1546.
   PubMed Web of Science ®Google Scholar
• Choi JY, Ramasamy T, Tran TH, Ku SK, Shin BS, Choi H-G, Yong CS, Kim JO. 2014. Systemic delivery of axitinib with nanohybrid liposomal nanoparticles inhibits hypoxic tumor growth. J Mater Chem B. 3:408–416.
   Web of Science ®Google Scholar
• Darvishi MH, Nomani A, Amini M, Shokrgozar MA, Dinarvand R. 2013. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells. Int J Pharm. 456:408–416.
   PubMed Web of Science ®Google Scholar
• Doktorovova S, Souto EB, Silva AM. 2014. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – a systematic review of in vitro data. . Eur J Pharm Biopharm. 87:1–18.
   PubMed Web of Science ®Google Scholar
• Gabriels M, Plaizier-Vercammen J. 2003. Physical and chemical evaluation of liposomes, containing artesunate. J Pharm Biomed Anal. 31:655–667.
   PubMed Web of Science ®Google Scholar
• Hamacher-Brady A, Stein HA, Turschner S, Toegel I, Mora R, Jennewein N, et al. 2011. Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. J Biol Chem. 286:6587–6601.
   PubMed Web of Science ®Google Scholar
• Jia L, Shen J, Zhang D, Duan C, Liu G, Zheng D, et al. 2012. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Int J Biol Macromol. 50:523–529.
   PubMed Web of Science ®Google Scholar
• Madane RG, Mahajan HS. 2015. Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study. Drug Deliv. 2015. [Epub ahead of print]. DOI: 10.3109/10717544.2014.975382.
   PubMed Web of Science ®Google Scholar
• Martins S, Costa-Lima S, Carneiro T, Cordeiro-Da-Silva A, Souto EB, Ferreira DC. 2012. Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway. Int J Pharm. 430:216–227.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. 2001. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 47:165–196.
   PubMed Web of Science ®Google Scholar
• Meng H, Xu K, Xu Y, Luo P, Du F, Huang J, et al. 2014. Nanocapsules based on mPEGylated artesunate prodrug and its cytotoxicity. Colloids Surf B Biointerfaces. 115:164–169.
   PubMed Web of Science ®Google Scholar
• Miao J, Du Y-Z, Yuan H, Zhang X-G, Hu F-Q. 2013. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells. Colloids Surf B Biointerfaces. 110:74–80.
   PubMed Web of Science ®Google Scholar
• Müller R, Radtke M, Wissing S. 2002. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 54:S131–S155.
   PubMed Web of Science ®Google Scholar
• Mussi SV, Silva RC, Oliveira MCD, Lucci CM, Azevedo RBD, Ferreira LM. 2013. New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles. Eur J Pharm Sci. 48:282–290.
   PubMed Web of Science ®Google Scholar
• Nguyen HT, Tran TH, Kim JO, Yong CS, Nguyen CN. 2015. Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-d, l-lactide-co-glycolide (PLGA) nanoparticles. Arch Pharm Res. 38:716–724.
   PubMed Web of Science ®Google Scholar
• Petersen S, Steiniger F, Fischer D, Fahr A, Bunjes H. 2011. The physical state of lipid nanoparticles influences their effect on in vitro cell viability. Eur J Pharm Biopharma. 79:150–161.
   PubMed Web of Science ®Google Scholar
• Ramasamy T, Haidar ZS, Tran TH, Choi JY, Jeong J-H, Shin BS, et al. 2014a. Layer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugs. Acta Biomater. 10:5116–5127.
   PubMed Web of Science ®Google Scholar
• Ramasamy T, Tran TH, Choi JY, Cho HJ, Kim JH, Yong CS, Choi H-G, Kim JO. 2014b. Layer-by-layer coated lipid–polymer hybrid nanoparticles designed for use in anticancer drug delivery. Carbohydr Polym. 102:653–661.
   PubMed Web of Science ®Google Scholar
• Shen J, Sun H, Meng Q, Yin Q, Zhang Z, Yu H, Li Y. 2014. Simultaneous inhibition of tumor growth and angiogenesis for resistant hepatocellular carcinoma by co-delivery of sorafenib and survivin small hairpin RNA. Mol Pharm. 11:3342–3351.
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Muller RH, Junyaprasert VB. 2007. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)-effects of formulation parameters on physicochemical stability. Int J Pharm. 340:198–206.
   PubMed Web of Science ®Google Scholar
• Torchilin V. 2011. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev. 63:131–135.
   PubMed Web of Science ®Google Scholar
• Tran TH, Choi JY, Ramasamy T, Truong DH, Nguyen CN, Choi H-G, Yong CS, Kim JO. 2014a. Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells. Carbohydr Polym. 114:407–415.
   PubMed Web of Science ®Google Scholar
• Tran TH, Ramasamy T, Truong DH, Choi HG, Yong CS, Kim JO. 2014b. Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement. AAPS Pharm Sci Tech. 15:1509–1515.
   PubMed Web of Science ®Google Scholar
• Tran TH, Ramasamy T, Truong DH, Shin BS, Choi HG, Yong CS, Kim JO. 2014c. Development of vorinostat-loaded solid lipid nanoparticles to enhance pharmacokinetics and efficacy against multidrug-resistant cancer cells. Pharm Res. 31:1978–1988.
   PubMed Web of Science ®Google Scholar
• Xie H, Yang B, Wang F, Zhao Y. 2015. Host–guest inclusion system of artesunate with β-cyclodextrin and its derivatives: characterization and antitumor activity. J Mol Struct. 1085:90–96.
   Web of Science ®Google Scholar
• Xu Q, Li ZX, Peng HQ, Sun ZW, Cheng RL, Ye ZM, Li WX. 2011. Artesunate inhibits growth and induces apoptosis in human osteosarcoma HOS cell line in vitro and in vivo. J Zhejiang Univ Sci B. 12:247–255.
   PubMed Web of Science ®Google Scholar
• Zhang XG, Miao J, Dai YQ, Du YZ, Yuan H, Hu FQ. 2008. Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells. Int J Pharm. 361:239–244.
   PubMed Web of Science ®Google Scholar